Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2023 Filed Feb 15, 2023 21:08 UTC |
Bodor RobertPresident and CEO
|
Tax withholdingCommon Stock | 2,053 | $34.23 | $70,274.19 |
DisclosureSEC source: 0001437749-23-003515 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,614 Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:05 UTC |
Klaas BjoernVP and Mng Director-PL Europe
|
Tax withholdingCommon Stock | 1,119 | $34.23 | $38,303.37 |
DisclosureSEC source: 0001437749-23-003511 · rdgdoc.xml · nonDerivative · entry 1 Klaas Bjoern · CIK 0001732855 · VP and Mng Director-PL Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,425 Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 21:03 UTC |
Schumacher DanielChief Financial Officer
|
Tax withholdingCommon Stock | 945 | $26.40 | $24,948.00 |
DisclosureSEC source: 0001437749-22-028403 · rdgdoc.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,096 Read SEC document |
| September 09, 2022 Filed Sep 13, 2022 20:55 UTC |
Ryaboy OlegChief Technology Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,307 | $0.00 Strike: $40.06 | $0.00 |
DisclosureSEC source: 0001437749-22-022332 · rdgdoc.xml · derivative · entry 2 Ryaboy Oleg · CIK 0001945827 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,307 Underlying: Common Stock · 6,307 shares Expires 2032-09-09 F2 · derivative.exercise_date: The stock option vest as to 25% of the shares in four annual installments beginning on February 13, 2023. Read SEC document |
| September 09, 2022 Filed Sep 13, 2022 20:55 UTC |
Ryaboy OlegChief Technology Officer
|
GrantCommon Stock | 9,361 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-022332 · rdgdoc.xml · nonDerivative · entry 1 Ryaboy Oleg · CIK 0001945827 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,361 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on February 13, 2023. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 23:03 UTC |
Schumacher DanielChief Financial Officer
|
GrantPerformance Stock Units · Derivative | 3,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021716 · rdgdoc.xml · derivative · entry 6 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,077 Underlying: Common Stock · 3,077 shares Expires 2024-12-31 F5 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. F5 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 23:03 UTC |
Schumacher DanielChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,317 | $0.00 Strike: $39.11 | $0.00 |
DisclosureSEC source: 0001437749-22-021716 · rdgdoc.xml · derivative · entry 5 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,317 Underlying: Common Stock · 6,317 shares Expires 2032-08-30 F4 · derivative.exercise_date: The stock option vest as to 25% of the shares in four annual installments beginning on February 13, 2023. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 23:03 UTC |
Schumacher DanielChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,288 | $0.00 Strike: $39.11 | $0.00 |
DisclosureSEC source: 0001437749-22-021716 · rdgdoc.xml · derivative · entry 4 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,288 Underlying: Common Stock · 2,288 shares Expires 2032-08-30 F3 · derivative.exercise_date: The stock option vest as to 25% of the shares in four annual installments beginning on May 20, 2023. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 23:03 UTC |
Schumacher DanielChief Financial Officer
|
GrantCommon Stock | 6,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021716 · rdgdoc.xml · nonDerivative · entry 3 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,041 F2 · shares: The restricted stock units vest in four annual equal installments beginning on February 13, 2023. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 23:03 UTC |
Schumacher DanielChief Financial Officer
|
GrantCommon Stock | 2,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021716 · rdgdoc.xml · nonDerivative · entry 2 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,887 F1 · shares: The restricted stock units vest in four annual equal installments beginning on May 20, 2023. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 19:02 UTC |
Greiner StacyDirector
|
GrantCommon Stock | 3,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021714 · rdgdoc.xml · nonDerivative · entry 1 Greiner Stacy · CIK 0001894943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,491 F1 · shares: The deferred stock units vest in full on May 18, 2023, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 23:08 UTC |
Black Archie C.Director
|
GrantCommon Stock | 3,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021722 · rdgdoc.xml · nonDerivative · entry 1 Black Archie C. · CIK 0001489095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 F1 · shares: The deferred stock units vest in full on May 18, 2023, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 23:08 UTC |
Chand SujeetDirector
|
GrantCommon Stock | 3,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021723 · rdgdoc.xml · nonDerivative · entry 1 Chand Sujeet · CIK 0001388884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 F1 · shares: The deferred stock units vest in full on May 18, 2023, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 23:07 UTC |
Chin MoonhieDirector
|
GrantCommon Stock | 3,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021721 · rdgdoc.xml · nonDerivative · entry 1 Chin Moonhie · CIK 0001395001 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,943 F1 · shares: The deferred stock units vest in full on May 18, 2023, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 23:06 UTC |
Gawlick RainerDirector
|
GrantCommon Stock | 3,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021719 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,015 F1 · shares: The deferred stock units vest in full on May 18, 2023, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 23:05 UTC |
WEHRWEIN SVENDirector
|
GrantCommon Stock | 3,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021718 · rdgdoc.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,142 F1 · shares: The deferred stock units vest in full on May 18, 2023, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 23:04 UTC |
KRANTZ DONALD GDirector
|
GrantCommon Stock | 3,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-021717 · rdgdoc.xml · nonDerivative · entry 1 KRANTZ DONALD G · CIK 0001183159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 F1 · shares: The restricted stock units vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2023 annual meeting of shareholders. Read SEC document |
| May 23, 2022 Filed May 25, 2022 22:13 UTC |
Kenison Michael R.VP and GM of the America's
|
Tax withholdingCommon Stock | 771 | $45.68 | $35,219.28 |
DisclosureSEC source: 0001437749-22-013565 · rdgdoc.xml · nonDerivative · entry 1 Kenison Michael R. · CIK 0001870293 · VP and GM of the America's 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,675 F1 · balance_after: Includes 225 shares of Common Stock of the issuer purchased on May 15, 2022 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| May 23, 2022 Filed May 25, 2022 22:13 UTC |
Schumacher DanielChief Financial Officer
|
Tax withholdingCommon Stock | 350 | $45.68 | $15,988.00 |
DisclosureSEC source: 0001437749-22-013566 · rdgdoc.xml · nonDerivative · entry 2 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,887 Read SEC document |
| May 23, 2022 Filed Sep 1, 2022 23:03 UTC |
Schumacher DanielChief Financial Officer
|
Tax withholdingCommon Stock | 350 | $45.68 | $15,988.00 |
DisclosureSEC source: 0001437749-22-021716 · rdgdoc.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,654 Read SEC document |
| May 18, 2022 Filed May 20, 2022 16:28 UTC |
Greiner StacyDirector
|
GrantCommon Stock | 3,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-013224 · rdgdoc.xml · nonDerivative · entry 1 Greiner Stacy · CIK 0001894943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,491 F1 · shares: The deferred stock units vest in full on May 18, 2023, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:32 UTC |
Black Archie C.Director
|
GrantCommon Stock | 3,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-013232 · rdgdoc.xml · nonDerivative · entry 1 Black Archie C. · CIK 0001489095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 F1 · shares: The deferred stock units vest in full on May 18, 2023, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:32 UTC |
Chand SujeetDirector
|
GrantCommon Stock | 3,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-013234 · rdgdoc.xml · nonDerivative · entry 1 Chand Sujeet · CIK 0001388884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 F1 · shares: The deferred stock units vest in full on May 18, 2023, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:30 UTC |
Chin MoonhieDirector
|
GrantCommon Stock | 3,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-013229 · rdgdoc.xml · nonDerivative · entry 1 Chin Moonhie · CIK 0001395001 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,943 F1 · shares: The deferred stock units vest in full on May 18, 2023, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:29 UTC |
Gawlick RainerDirector
|
GrantCommon Stock | 3,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-013227 · rdgdoc.xml · nonDerivative · entry 1 Gawlick Rainer · CIK 0001542473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,015 F1 · shares: The deferred stock units vest in full on May 18, 2023, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:27 UTC |
KRANTZ DONALD GDirector
|
GrantCommon Stock | 3,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-013221 · rdgdoc.xml · nonDerivative · entry 1 KRANTZ DONALD G · CIK 0001183159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 F1 · shares: The restricted stock units vest in full on the earlier of the first anniversary of the grant date or the date of the Company's 2023 annual meeting of shareholders. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:26 UTC |
WEHRWEIN SVENDirector
|
GrantCommon Stock | 3,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-013218 · rdgdoc.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,142 F1 · shares: The deferred stock units vest in full on May 18, 2023, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 18, 2022 Filed May 25, 2022 22:13 UTC |
Schumacher DanielChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,288 | $0.00 Strike: $44.81 | $0.00 |
DisclosureSEC source: 0001437749-22-013566 · rdgdoc.xml · derivative · entry 3 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,288 Underlying: Common Stock · 2,288 shares Expires 2032-05-18 F2 · derivative.exercise_date: The stock option vest as to 25% of the shares in four annual installments beginning on May 20, 2023. Read SEC document |
| May 18, 2022 Filed May 25, 2022 22:13 UTC |
Schumacher DanielChief Financial Officer
|
GrantCommon Stock | 2,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-013566 · rdgdoc.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,237 F1 · shares: The restricted stock units vest as to 25% of the shares in four annual installments beginning on May 20, 2023. Read SEC document |
| February 17, 2022 Filed Feb 17, 2022 21:07 UTC |
Baker Arthur R. IIIChief Technology Officer
|
Tax withholdingCommon Stock | 1,388 | $56.34 | $78,199.92 |
DisclosureSEC source: 0001437749-22-003677 · rdgdoc.xml · nonDerivative · entry 2 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,307 Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:04 UTC |
Kenison Michael R.VP and GM of the America's
|
GrantPerformance Stock Units · Derivative | 1,894 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-003674 · rdgdoc.xml · derivative · entry 3 Kenison Michael R. · CIK 0001870293 · VP and GM of the America's 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,894 Underlying: Common Stock · 1,894 shares Expires 2024-12-31 F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. F4 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:04 UTC |
Kenison Michael R.VP and GM of the America's
|
GrantEmployee Stock Option (right to buy) · Derivative | 4,042 | $0.00 Strike: $59.40 | $0.00 |
DisclosureSEC source: 0001437749-22-003674 · rdgdoc.xml · derivative · entry 2 Kenison Michael R. · CIK 0001870293 · VP and GM of the America's 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,042 Underlying: Common Stock · 4,042 shares Expires 2032-02-13 F3 · derivative.exercise_date: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:04 UTC |
Kenison Michael R.VP and GM of the America's
|
GrantCommon Stock | 3,788 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-003674 · rdgdoc.xml · nonDerivative · entry 1 Kenison Michael R. · CIK 0001870293 · VP and GM of the America's 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,221 F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested. F2 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person including 95 shares purchased on November 15, 2021 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:07 UTC |
Baker Arthur R. IIIChief Technology Officer
|
GrantPerformance Stock Units · Derivative | 2,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-003677 · rdgdoc.xml · derivative · entry 4 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,947 Underlying: Common Stock · 2,947 shares Expires 2024-12-31 F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. F4 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:07 UTC |
Baker Arthur R. IIIChief Technology Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 6,287 | $0.00 Strike: $59.40 | $0.00 |
DisclosureSEC source: 0001437749-22-003677 · rdgdoc.xml · derivative · entry 3 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,287 Underlying: Common Stock · 6,287 shares Expires 2032-02-13 F3 · derivative.exercise_date: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:07 UTC |
Baker Arthur R. IIIChief Technology Officer
|
GrantCommon Stock | 5,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-003677 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,695 F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested. F2 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person including 188 shares purchased on May 15, 2021 and 1 share purchased on November 15, 2021 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:07 UTC |
Klaas BjoernVP and Mng Director-PL Europe
|
GrantPerformance Stock Units · Derivative | 1,894 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-003678 · rdgdoc.xml · derivative · entry 3 Klaas Bjoern · CIK 0001732855 · VP and Mng Director-PL Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,894 Underlying: Common Stock · 1,894 shares Expires 2024-12-31 F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:07 UTC |
Klaas BjoernVP and Mng Director-PL Europe
|
GrantEmployee Stock Option (right to buy) · Derivative | 4,042 | $0.00 Strike: $59.40 | $0.00 |
DisclosureSEC source: 0001437749-22-003678 · rdgdoc.xml · derivative · entry 2 Klaas Bjoern · CIK 0001732855 · VP and Mng Director-PL Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,042 Underlying: Common Stock · 4,042 shares Expires 2032-02-13 F2 · derivative.exercise_date: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:07 UTC |
Klaas BjoernVP and Mng Director-PL Europe
|
GrantCommon Stock | 3,788 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-003678 · rdgdoc.xml · nonDerivative · entry 1 Klaas Bjoern · CIK 0001732855 · VP and Mng Director-PL Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,544 F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:06 UTC |
Bodor RobertPresident and CEO
|
GrantPerformance Stock Units · Derivative | 23,570 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-003676 · rdgdoc.xml · derivative · entry 3 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,570 Underlying: Common Stock · 23,570 shares Expires 2024-12-31 F4 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. F4 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of Proto Labs, Inc. common stock. The performance stock units vest upon Proto Labs, Inc. common stock achieving a specified price per share. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:06 UTC |
Bodor RobertPresident and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 25,147 | $0.00 Strike: $59.40 | $0.00 |
DisclosureSEC source: 0001437749-22-003676 · rdgdoc.xml · derivative · entry 2 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,147 Underlying: Common Stock · 25,147 shares Expires 2032-02-13 F3 · derivative.exercise_date: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:06 UTC |
Bodor RobertPresident and CEO
|
GrantCommon Stock | 11,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-003676 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,667 F1 · shares: Restricted Stock Units that vest as follows: 25% of shares subject to the award will vest on February 13, 2023, and on each February 13th thereafter until all shares subject to the award are fully vested. F2 · balance_after: Reports the total number of shares of Common Stock of the issuer held by the reporting person including 188 shares purchased on May 15, 2021 through the issuer's Employee Stock Purchase Plan program. Read SEC document |
| February 13, 2022 Filed Feb 15, 2022 21:01 UTC |
Klaas BjoernVP and Mng Director-PL Europe
|
Tax withholdingCommon Stock | 728 | $56.34 | $41,015.52 |
DisclosureSEC source: 0001437749-22-003407 · rdgdoc.xml · nonDerivative · entry 1 Klaas Bjoern · CIK 0001732855 · VP and Mng Director-PL Europe 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,756 Read SEC document |
| December 03, 2021 Filed Dec 6, 2021 21:44 UTC |
Bodor RobertPresident and CEO
|
PurchaseCommon Stock | 3,138 | $47.87 | $150,218.88 |
DisclosureSEC source: 0001437749-21-027938 · rdgdoc.xml · nonDerivative · entry 1 Bodor Robert · CIK 0001581088 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,694 Read SEC document |
| December 01, 2021 Filed Dec 1, 2021 19:55 UTC |
Baker Arthur R. IIIChief Technology Officer
|
PurchaseCommon Stock | 10,000 | $49.21 | $492,100.00 |
DisclosureSEC source: 0001437749-21-027612 · rdgdoc.xml · nonDerivative · entry 1 Baker Arthur R. III · CIK 0001536324 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,613 Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:22 UTC |
Schumacher DanielChief Financial Officer
|
GrantCommon Stock | 3,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-027846 · rdgdoc.xml · nonDerivative · entry 1 Schumacher Daniel · CIK 0001894753 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,004 F1 · shares: Restricted Stock Units that will vest 100% on December 1, 2022. Read SEC document |
| November 15, 2021 Filed Nov 22, 2021 13:26 UTC |
Greiner StacyDirector
|
GrantCommon Stock | 2,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-027225 · rdgdoc.xml · nonDerivative · entry 2 Greiner Stacy · CIK 0001894943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,255 F2 · shares: The deferred stock units vest in full on November 15, 2021, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| November 15, 2021 Filed Nov 22, 2021 13:26 UTC |
Greiner StacyDirector
|
GrantCommon Stock | 767 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-027225 · rdgdoc.xml · nonDerivative · entry 1 Greiner Stacy · CIK 0001894943 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 767 F1 · shares: The deferred stock units vest in full on May 18, 2022, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:06 UTC |
Black Archie C.Director
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-012958 · rdgdoc.xml · nonDerivative · entry 1 Black Archie C. · CIK 0001489095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,264 F1 · shares: The deferred stock units vest in full on May 18, 2022, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:04 UTC |
Chand SujeetDirector
|
GrantCommon Stock | 1,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-012955 · rdgdoc.xml · nonDerivative · entry 1 Chand Sujeet · CIK 0001388884 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,264 F1 · shares: The deferred stock units vest in full on May 18, 2022, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.